MYP_058397
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral Anti-HIV
Antiviral Antiviral mechanism Viral entry inhibition
Standard
30 amino acids
C148H228N38O43S6
Standard
Sequence
KIPCGESCVWIPCVTSIFNCKCENKVCYHD
Physicochemical Analysis
3420.01 Da
6.72
-0.21
-0.56
-0.0069
0.11
0.41
0.10
15.02
68.00
0.1000
6990.00
7365.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1291.17
-11.63
49.0
50.0
107.0
235.0
7.0
31.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0321804 VERIFIED: YES
Provenance & Taxonomy
Chassalia parviflora [Animal]
Defensin
Structure & Mods
side-chain cyclized peptide [Cyclic]
canonical L-amino-acid peptide [L]
Cyclization
Cyclization
4-20, 8-22, 13-27
Bio-Activity Profile
Antimicrobial Antiviral
RECORD: Rec_0327952 VERIFIED: YES
Provenance & Taxonomy
Chassalia parviflora [Plant]
Defensin
58431
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
Cyclization (N termini to C termini)
Cyclization (N termini to C termini)
4-20, 8-22, 13-27
Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27.
Bio-Activity Profile
Antiviral Anti-HIV Entry inhibition
HIV
0.05-0.275 μM
EC50
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min
Showing 2 records on this page · Page 2 of 2